Home Newsfeeds Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

Analyst Ratings

What 10 Analyst Ratings Have To Say About Amedisys

By Benzinga Insights

March 13, 8:01 AM

Within the last quarter, Amedisys (NASDAQ:AMED) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

AMED

LGI Homes Sees FY22 Home Closings Of 6,700 – 7,100 at ASP of $340K – $350K

By Benzinga Newsdesk

November 1, 7:41 AM

Full Year 2022 Outlook Subject to the caveats in the Forward-Looking Statements section of this press release, the Company is providing the following updates to its guidance for the full year 2022. The Company now

LGIH

News

XP’s Active Clients In 3Q23 Grew 10% QoQ And 16% YoY, Totaling 4.4M; Net Inflow Was Up 118% QoQ And 38% YoY

By Benzinga Newsdesk

October 25, 2:44 AM

Client Assets and Net Inflow (in R$ billion) Client Assets totaled R$1.1 trillion as of September 30th, up 17% YoY and 6% QoQ. Year-over-year growth was driven by R$117 billion net inflows and R$38

News

Daxor Corporation Announces Further Acquisitions And Increased Utilization Of Its BVA-100 Blood Volume Diagnostic Throughout The U.S.

By Happy Mohamed

July 11, 8:26 AM

Daxor Adds a Six-Facility Hospital System with ezBVA Lab and Expands Treatment Areas Among Existing Accounts Oak Ridge, TN, July 11, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the

DXR

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Related Posts

What 10 Analyst Ratings Have To Say About Amedisys

LGI Homes Sees FY22 Home Closings Of 6,700 – 7,100 at ASP of $340K – $350K

XP’s Active Clients In 3Q23 Grew 10% QoQ And 16% YoY, Totaling 4.4M; Net Inflow Was Up 118% QoQ And 38% YoY

Daxor Corporation Announces Further Acquisitions And Increased Utilization Of Its BVA-100 Blood Volume Diagnostic Throughout The U.S.